当前位置:首页 - 行情中心 - 南微医学(688029) - 财务分析

南微医学

(688029)

  

流通市值:120.24亿  总市值:120.24亿
流通股本:1.88亿   总股本:1.88亿

南微医学(688029)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润1.67亿元,每股收益0.86元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益414319.53万元,未分配利润182513.73万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产493123.55万元,负债78804.02万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入699,156,940.32,755,434,907.162,012,446,160.411,333,844,008.46
营业总成本501,585,822.522,064,317,241.621,467,685,015.45958,202,375.17
营业利润197,938,915.61659,411,813.09540,081,506.91371,678,707.04
利润总额197,789,505.94659,773,354.26542,246,606.61373,095,091.63
净利润167,162,271.01568,077,232.03464,032,872.96319,998,746.09
其他综合收益9,159,697.471,494,630.66-1,088,120.39-2,329,147.63
综合收益总额176,321,968.48569,571,862.69462,944,752.57317,669,598.46
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计3,223,440,427.413,320,779,018.73,285,106,650.113,190,639,200.81
非流动资产合计1,707,795,061.181,458,827,931.111,281,491,410.031,225,062,309.34
资产总计4,931,235,488.594,779,606,949.814,566,598,060.144,415,701,510.15
流动负债合计707,067,941.17806,488,497.71688,839,737.98577,895,191.44
非流动负债合计80,972,240.4273,754,998.4275,471,081.7576,163,445.94
负债合计788,040,181.59880,243,496.13764,310,819.73654,058,637.38
归属于母公司股东权益合计3,994,462,762.083,826,092,661.233,731,107,640.053,693,869,584.9
股东权益合计4,143,195,3073,899,363,453.683,802,287,240.413,761,642,872.77
负债和股东权益合计4,931,235,488.594,779,606,949.814,566,598,060.144,415,701,510.15
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计764,204,278.582,832,647,112.982,109,854,672.771,425,742,315.41
经营活动现金流出小计693,637,180.932,219,625,224.91,728,198,034.921,152,100,440.22
经营活动产生的现金流量净额70,567,097.65613,021,888.08381,656,637.85273,641,875.19
投资活动现金流入小计301,639,221.672,167,204,313.352,314,666,583.31,747,329,453.92
投资活动现金流出小计382,747,050.071,754,836,597.562,369,981,632.581,768,361,005.43
投资活动产生的现金流量净额-81,107,828.4412,367,715.79-55,315,049.28-21,031,551.51
筹资活动现金流入小计----
筹资活动现金流出小计18,297,618.67357,481,298.67246,597,988.32230,985,453.4
筹资活动产生的现金流量净额-18,297,618.67-357,481,298.67-246,597,988.32-230,985,453.4
汇率变动对现金及现金等价物的影响13,594,512.6-6,954,827.84-7,449,033.53-7,599,861.78
现金及现金等价物净增加额-15,243,836.82660,953,477.3672,294,566.7214,025,008.5
期末现金及现金等价物余额1,854,972,301.381,870,216,138.21,281,557,227.561,223,287,669.34
最新报告期:2025-05-08
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
兴业证券东楠,孙媛媛,黄翰漾3.544.174.872025-05-08
中泰证券于佳喜,祝嘉琦,谢木青3.564.385.332025-05-08
国盛证券杨芳,张金洋3.514.245.102025-05-07
东吴证券朱国广3.494.094.942025-05-02
中金公司俞波,张琎,冯喜鹏3.774.43--2025-04-30
TOP↑